Counsel Opinion Filed for Equity Offering
Aptevo Therapeutics filed an exhibit 5.1 legal opinion in relation to a sales agreement authorizing the sale of up to $2.3M in common stock, by Roth Capital Partners.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed